Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines
Clinical guideline published by European Malignant Hyperthermia Group (EMHG) on
The European Malignant Hyperthermia Group (EMHG) is dedicated to improving the understanding and diagnosis of malignant hyperthermia (MH). Established in 1983, it promotes research, provides guidelines for MH susceptibility testing, and maintains a registry for MH events.